CAMBRIDGE, MASS. — Terrain Biosciences will open a new, 14,000-square-foot headquarters facility in Cambridge, located across the Charles River from Boston. The RNA therapeutics company will relocate from the nearby building at 400 Technology Way to Genesis 640 Memorial Drive, a 248,000-square-foot office and lab facility. CBRE represented the landlord, Phase 3 Real Estate Partners, in the lease negotiations. Colliers represented Terrain Bio. A timeline for occupancy was not announced.
BEDFORD, MASS. — Lantheus has signed a 41,000-square-foot office and life sciences lease in Bedford, a northwestern suburb of Boston.The provider of diagnostic and therapeutic products and services is taking space at The Core @ Crosby, a nine-building, 592,000-square-foot campus. Cushman & Wakefield represented Lantheus in the lease negotiations. The landlord is a partnership between Boston-based investment firm Anchor Line Partners and Alloy Properties, the national life sciences platform of TPG Real Estate.
KENILWORTH, N.J. — Newmark has brokered the $322 million sale of a facility within the Northeast Science & Technology Center, a 107-acre data center and life sciences campus located in the Northern New Jersey community of Kenilworth. Spanning roughly 2 million square feet and formerly owned and occupied by pharmaceutical company Merck, the campus comprises nine buildings with office, lab and research-and-development space, as well as a 50-megawatt substation, cogeneration and chiller plants and a central boiler facility. The buyer, New Jersey-based data center owner-operator CoreWeave, committed last fall to a 280,000-square-foot lease and a larger $1.2 billion investment at the property. The seller, a partnership between Onyx Equities and Machine Investment Group, bought the campus in 2023 for $187.5 million with plans to reposition the property into a life sciences and innovation hub. The Newmark deal team included Andrew Warin, Josh King, Brent Mayo, Doug Harmon and Jordan Roeschlaub. Cushman & Wakefield represented the buyer in the transaction.
— By Chris High, Steve Bruce and Conor Evans of Colliers — We’re in the middle of a market recalibration. On the office side, leasing has slowed significantly, with tenants downsizing footprints and pushing for shorter terms as hybrid work remains a dominant driver. In life sciences, we saw explosive growth from 2020 to mid-2022, but that pace has tapered off. VC funding is more selective, and some developers who stretched to convert commodity office and flex properties into lab space, often with less-than-ideal infrastructure, during the boom years, are now rethinking those strategies. Still, demand for high-quality, fitted lab space remains, especially in well-located projects by experienced owners like Longfellow, BioScience Properties, Sterling Bay, Healthpeak, BioMed, and ARE. These firms are adapting with thoughtful repositioning and delivering product that aligns with where tenant demand is today. In the near term, we expect continued headwinds. Commodity office space will face pressure on rents and absorption, while high-end life science campuses with strong sponsorship will be better positioned to attract demand. We expect Life Science to rebound in the next 12 to 18 months as capital markets settle and merger/acquisition (M&A) activity returns. Distressed office sales may continue as debt maturities …
NEW BRUNSWICK, N.J. — New York City-based developer SJP Properties has broken ground on a 370,000-square-foot office and life sciences project in the Central New Jersey community of New Brunswick. The 10-story building will be known as the Nokia Bell Labs Headquarters facility and represents Phase II of a larger development known as the HELIX NJ Innovation District (previously known as HELIX Health + Life Science Exchange). SJP is developing the HELIX project in partnership with the New Brunswick Development Corp. PNC Bank provided construction financing for the project, completion of which is slated for late 2027.
LAUREL HOLLOW, N.Y. — International development and construction firm Skanska has topped out a $248 million life sciences project in Laurel Hollow, located on Long Island. The 379,500-square-foot facility is known as the Artificial Intelligence and Quantitative Biology building and is part of the initial phase of the expansion of the Cold Spring Harbor Laboratory campus. Upon completion, the facility will include neuroscience labs, an AI research center, conference center and housing for visiting scientists. Phase II of the development will feature an 81,000-square-foot research, housing and conference center and a 56,000-square-foot housing and collaborative research center for visiting scientists. Empire State Development has committed $55 million in funding to the project, substantial completion of which is expected by early 2027.
CHICAGO — Beacon Capital Partners and Trammell Crow Co. (TCC) have completed Hyde Park Labs in Chicago. The partnership has also opened its STEM engagement center for local youth, Southside STEM Station, on the ground floor of the 300,000-square-foot development. The learning hub offers free STEM programs for students, families and educators on the city’s South Side. Located at 5207 S. Harper Ave. and rising 13 stories, Hyde Park Labs features nine full floors of Class A lab and office space, ground-level retail and four levels of parking. The developers say the project marks the South Side of Chicago’s first commercial, purpose-built advanced R&D lab building. More than 40,000 square feet of tenant amenities includes a fifth-floor terrace dubbed “The Lawn” with grills, firepits and direct access to the interior tenant lounge. The development also features private terraces on each floor, secure bike storage, an indoor bar and lounge and an executive boardroom. The University of Chicago has pre-leased approximately 55,000 square feet at Hyde Park Labs. In addition to faculty research, the university’s space includes its new UChicago Science Incubator, a partnership between the Polsky Center for Entrepreneurship and Innovation and Portal Innovations. Five UChicago-affiliated companies are among the …
MORRISVILLE, N.C. — Liquidia Corp., a publicly traded biopharmaceutical firm specializing in therapies for those suffering from rare cardiopulmonary diseases, has signed an approximately 70,000-square-foot lease in North Carolina’s Research Triangle region. The company will occupy space at Building 1 at Pathway Triangle, a 1 million-square-foot life sciences development located at 1000 Science Drive in Morrisville, less than three miles from Raleigh-Durham International Airport and 11 miles northwest of North Carolina State University. King Street Properties, the landlord and developer of Pathway Triangle, recently broke ground on an amenity center on the campus called The Junction, which will feature meeting rooms, conference space, a fitness center and dining options. Liquidia Corp. recently received FDA approval for YUTREPIA, the company’s trademarked treprostinil inhalation powder. The locally based firm will begin operating at Pathway Triangle in 2026.
TOPEKA, KAN. — Construction has begun on Link Innovation Labs, an 18,000-square-foot innovation incubator in downtown Topeka. Formerly corporate offices for AT&T, the redevelopment project is set to open in January 2026 and will feature wet and dry labs, coworking areas, conference rooms, offices and a coffee shop. The first tenant is Plug and Play Topeka, a launchpad for startups in animal health, ag-tech and food systems. Eight wet and dry labs will total roughly 7,500 square feet. A pitch and event area will span 2,500 square feet and will be dedicated to networking, presentations, conferences and public training events. Link Innovation Labs has $5 million committed from public and private sources. GO Topeka is leading the project. Topeka is centrally located within the Kansas City Animal Health Corridor, the world’s largest concentration of animal health companies and related industries.
BOSTON — Related Beal, the Boston office of Related Cos., has topped out construction of Leiden Center II at Innovation Square, a 345,000-square-foot life sciences project in Boston. The 1.8-acre site is located within Raymond L. Flynn Marine Park in the Seaport District, and the seven-story building, which represents Phase III of the larger Innovation Square development, is fully preleased to Vertex Pharmaceuticals. A consortium of lenders consisting of Santander Bank, Ullico, LBBW and Washington Capital provided construction financing for the project, in which Basis Investment Group is an equity investor. Completion is slated for early 2027. The project is expected to generate as many as 700 construction jobs and approximately 500 permanent jobs for the city.
Newer Posts